Medicines for treating ADHD will now include information written with youngsters and teens in mind, thanks to work by researchers at the University of Leeds and the MHRA.
This is the first time that a dedicated ‘youth friendly’ section has been added to the patient information leaflet provided with any medicine taken by under-18s.
The new section is designed to help children with attention deficit-hyperactivity disorder (ADHD) understand more about the medicines they take and how to take them safely. It is also helping young people feel included in discussions about their treatment.
The full press release can be read on the University of Leeds' website.